BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 6 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34 | -20.9% | 679 | 0.0% | 0.00% | – |
Q2 2023 | $43 | +16.2% | 679 | -17.7% | 0.00% | – |
Q1 2023 | $37 | -14.0% | 825 | -16.3% | 0.00% | – |
Q4 2022 | $43 | -99.9% | 986 | +51.2% | 0.00% | – |
Q3 2022 | $43,000 | -56.6% | 652 | -57.9% | 0.00% | – |
Q1 2022 | $99,000 | -30.8% | 1,548 | +16.0% | 0.00% | – |
Q4 2021 | $143,000 | +20.2% | 1,335 | +15.2% | 0.00% | – |
Q3 2021 | $119,000 | +85.9% | 1,159 | +59.2% | 0.00% | – |
Q2 2021 | $64,000 | +93.9% | 728 | +116.7% | 0.00% | – |
Q1 2021 | $33,000 | – | 336 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |